Direct-to-consumer Advertising Of Prescription Drugs What Are The Consequences? Hearing Before The Special Committee On Aging, U.s. Senate

Witnesses: Janet Woodcock, M.D., Dir., Center for Drug Evaluation & Research, Food & Drug Admin. (FDA); Marjorie Powell, Sr. Assist. Gen. Counsel, Pharma, Wash., DC; Nancy Nielsen, M.D., Ph.D., Speaker of the House of Delegates, Amer. Med. Assoc., Wash., DC; Meredith B. Rosenthal, Ph.D., Dept. of Health Policy & Mgmt., Harvard School of Public Health, Boston, MA; & Arnold Relman, M.D., Prof. Emeritus of Medicine & of Social Medicine, Harvard Medical School, Boston, MA. Appendix: Testimony submitted on behalf of the Henry J. Kaiser Family Foundation; & Statement of The Center for Patient Advocacy.Craig, Larry is the author of 'Direct-to-consumer Advertising Of Prescription Drugs What Are The Consequences? Hearing Before The Special Committee On Aging, U.s. Senate', published 2004 under ISBN 9780756732257 and ISBN 0756732255.